Literature DB >> 18803686

Defeating pathogen drug resistance: guidance from evolutionary theory.

John W Pepper1.   

Abstract

Many of the greatest challenges in medicine and public health involve the evolution of drug resistance by pathogens. Recent advances in the theory of natural selection suggest that there are two broad classes of pathogen traits that can be targeted by drugs or vaccines. The first class, consisting of traits that benefit the individual organisms bearing them, causes a strong evolutionary response and the rapid emergence of drug resistance. The second class, consisting of traits that benefit groups of pathogen organisms including the individual provider, causes a weaker evolutionary response and less drug resistance. Although most previous drug development has targeted the first class, it would be advantageous to focus on the second class as targets for drug and vaccine development. Specific examples and test cases are discussed.

Mesh:

Year:  2008        PMID: 18803686     DOI: 10.1111/j.1558-5646.2008.00525.x

Source DB:  PubMed          Journal:  Evolution        ISSN: 0014-3820            Impact factor:   3.694


  17 in total

1.  Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility.

Authors:  C Athena Aktipis; Carlo C Maley; John W Pepper
Journal:  Cancer Prev Res (Phila)       Date:  2011-09-19

2.  Viral resistance evolution fully escapes a rationally designed lethal inhibitor.

Authors:  Thomas E Keller; Ian J Molineux; James J Bull
Journal:  Mol Biol Evol       Date:  2009-06-03       Impact factor: 16.240

Review 3.  Tumorigenesis: it takes a village.

Authors:  Doris P Tabassum; Kornelia Polyak
Journal:  Nat Rev Cancer       Date:  2015-07-02       Impact factor: 60.716

Review 4.  Opinion: Control vs. eradication: applying infectious disease treatment strategies to cancer.

Authors:  Gunther Jansen; Robert Gatenby; C Athena Aktipis
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-27       Impact factor: 11.205

5.  What can ecology teach us about cancer?

Authors:  Irina Kareva
Journal:  Transl Oncol       Date:  2011-10-01       Impact factor: 4.243

6.  Evaluation of a novel therapeutic approach to treating severe pneumococcal infection using a mouse model.

Authors:  Nikkol Melnick; Gowrisankar Rajam; George M Carlone; Jacquelyn S Sampson; Edwin W Ades
Journal:  Clin Vaccine Immunol       Date:  2009-04-22

7.  Drugs that target pathogen public goods are robust against evolved drug resistance.

Authors:  John W Pepper
Journal:  Evol Appl       Date:  2012-11       Impact factor: 5.183

8.  Cancer research meets evolutionary biology.

Authors:  John W Pepper; C Scott Findlay; Rees Kassen; Sabrina L Spencer; Carlo C Maley
Journal:  Evol Appl       Date:  2009-02       Impact factor: 5.183

9.  Prisoner's dilemma in cancer metabolism.

Authors:  Irina Kareva
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  The evolution of bacterial social life: From the ivory tower to the front lines of public health.

Authors:  John W Pepper
Journal:  Evol Med Public Health       Date:  2014-03-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.